{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:28:28Z","timestamp":1793053708822,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016346","name":"Second Hospital of Tianjin Medical University","doi-asserted-by":"publisher","award":["MNRC202312"],"award-info":[{"award-number":["MNRC202312"]}],"id":[{"id":"10.13039\/501100016346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016346","name":"Second Hospital of Tianjin Medical University","doi-asserted-by":"publisher","award":["MYSRC202306"],"award-info":[{"award-number":["MYSRC202306"]}],"id":[{"id":"10.13039\/501100016346","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Science and Technology Project","award":["21ZXJBSY00090"],"award-info":[{"award-number":["21ZXJBSY00090"]}]},{"name":"Tianjin Science and Technology Project","award":["24JCYBJC01040"],"award-info":[{"award-number":["24JCYBJC01040"]}]},{"name":"Tianjin Science and Technology Project","award":["KJ20169"],"award-info":[{"award-number":["KJ20169"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1245\/s10434-025-17980-9","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T19:57:57Z","timestamp":1754337477000},"page":"807-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparing Regional Saturation Biopsy and Targeted Biopsy: Is Perilesional Biopsy Necessary for High-Prostate-Specific Antigen Patients?"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5239-9933","authenticated-orcid":false,"given":"Mingzhe","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-4567","authenticated-orcid":false,"given":"Shanqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-4430","authenticated-orcid":false,"given":"Ranlu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-3498","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-1655","authenticated-orcid":false,"given":"Xingkang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"17980_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. Epub 2024 Jan 17. Erratum in: CA Cancer J Clin. 2024 Mar-Apr;74(2):203","DOI":"10.3322\/caac.21820"},{"issue":"4","key":"17980_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41585-022-00684-0","volume":"20","author":"MJ Connor","year":"2023","unstructured":"Connor MJ, Gorin MA, Eldred-Evans D, Bass EJ, Desai A, Dudderidge T, et al. Landmarks in the evolution of prostate biopsy. Nat Rev Urol. 2023;20(4):241\u201358. https:\/\/doi.org\/10.1038\/s41585-022-00684-0.","journal-title":"Nat Rev Urol."},{"issue":"6","key":"17980_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/JU.0000000000003452","volume":"209","author":"W Lowrance","year":"2023","unstructured":"Lowrance W, Dreicer R, Jarrard DF, Scarpato KR, Kim SK, Kirkby E, et al. Updates to advanced prostate cancer: AUA\/SUO Guideline (2023). J Urol. 2023;209(6):1082\u201390. https:\/\/doi.org\/10.1097\/JU.0000000000003452.","journal-title":"J Urol."},{"issue":"5","key":"17980_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.eururo.2023.01.012","volume":"83","author":"J Stranne","year":"2023","unstructured":"Stranne J, Mottet N, Rouvi\u00e8re O. Systematic biopsies as a complement to magnetic resonance imaging-targeted biopsies:\" to be or not to be\"? European Urol. 2023;83(5):381\u20134. https:\/\/doi.org\/10.1016\/j.eururo.2023.01.012.","journal-title":"European Urol"},{"issue":"3","key":"17980_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","volume":"71","author":"M Borghesi","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017;71(3):353\u201365. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.004.","journal-title":"Eur Urol."},{"issue":"40","key":"17980_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.euros.2022.04.001","volume":"2","author":"MJ Hagens","year":"2022","unstructured":"Hagens MJ, Fernandez Salamanca M, Padhani AR, van Leeuwen PJ, van der Poel HG, Schoots IG. Diagnostic performance of a magnetic resonance imaging-directed targeted plus regional biopsy approach in prostate cancer diagnosis: a systematic review and meta-analysis. Eur Urol Open Sci. 2022;2(40):95\u2013103. https:\/\/doi.org\/10.1016\/j.euros.2022.04.001.","journal-title":"Eur Urol Open Sci."},{"issue":"4","key":"17980_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.eururo.2024.07.001","volume":"86","author":"O Rouvi\u00e8re","year":"2024","unstructured":"Rouvi\u00e8re O, van Leenders GJ, Eberli D. EAU-EANM-ESTRO-ESUR-ISUP-siog prostate cancer guidelines panel. systematic prostate biopsy versus perilesional sampling: if it isn\u2019t broke, why fix it. European Urol. 2024;86(4):295\u20136. https:\/\/doi.org\/10.1016\/j.eururo.2024.07.001.","journal-title":"European Urol"},{"issue":"24","key":"17980_CR8","doi-asserted-by":"publisher","first-page":"00234","DOI":"10.1016\/j.euo.2024.10.006","volume":"S2588\u20139311","author":"F Sanguedolce","year":"2024","unstructured":"Sanguedolce F, Lauwers CNG, Tedde A, Basile G, Chernysheva D, Uleri A, et al. Regional versus systematic biopsy in addition to targeted biopsy: results from a systematic review and meta-analysis. Eur Urol Oncol. 2024;S2588\u20139311(24):00234\u20137. https:\/\/doi.org\/10.1016\/j.euo.2024.10.006.","journal-title":"Eur Urol Oncol."},{"issue":"9","key":"17980_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41585-022-00638-6","volume":"19","author":"H Van Poppel","year":"2022","unstructured":"Van Poppel H, Albreht T, Basu P, et al. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat Rev Urol. 2022;19(9):562\u201372. https:\/\/doi.org\/10.1038\/s41585-022-00638-6.","journal-title":"Nat Rev Urol."},{"key":"17980_CR10","doi-asserted-by":"publisher","first-page":"656444","DOI":"10.3389\/fonc.2021.656444","volume":"11","author":"P Mandel","year":"2021","unstructured":"Mandel P, Hoeh B, Preisser F, et al. Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy. Front Oncol. 2021;11:656444. https:\/\/doi.org\/10.3389\/fonc.2021.656444.","journal-title":"Front Oncol."},{"issue":"3","key":"17980_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","volume":"82","author":"WG Brisbane","year":"2022","unstructured":"Brisbane WG, Priester AM, Ballon J, et al. Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling. Eur Urol. 2022;82(3):303\u201310. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.008.","journal-title":"Eur Urol."},{"issue":"4","key":"17980_CR12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.euo.2023.12.002","volume":"7","author":"X Jiang","year":"2024","unstructured":"Jiang X, Chen M, Tian J, et al. Comparison of regional saturation biopsy, targeted biopsy, and systematic biopsy in patients with prostate- specific antigen levels of 4\u201320 ng\/ml: a prospective, single-center, randomized controlled trial. Eur Urol Oncol. 2024;7(4):944\u201353. https:\/\/doi.org\/10.1016\/j.euo.2023.12.002.","journal-title":"Eur Urol Oncol."},{"key":"17980_CR13","doi-asserted-by":"publisher","first-page":"6230","DOI":"10.12659\/MSM.915826","volume":"25","author":"Y Chen","year":"2019","unstructured":"Chen Y, Jiang X, Liu R, et al. The specific choice of transrectal ultrasound-guided prostate biopsy scheme based on prostate specific antigen and prostate specific antigen density. Med Sci Monit. 2019;25:6230\u20135. https:\/\/doi.org\/10.12659\/MSM.915826.","journal-title":"Med Sci Monit."},{"issue":"5","key":"17980_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/13685538.2019.1620204","volume":"23","author":"A Ozorak","year":"2020","unstructured":"Ozorak A, Zumrutbas AE, Bingol G, et al. Prostate cancer incidence and diagnosis in men with PSA levels >20 ng\/ml: is it possible to decrease the number of biopsy cores? Aging Male. 2020;23(5):893\u2013900. https:\/\/doi.org\/10.1080\/13685538.2019.1620204.","journal-title":"Aging Male."},{"issue":"3","key":"17980_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41391-022-00620-8","volume":"26","author":"JP Noujeim","year":"2023","unstructured":"Noujeim JP, Belahsen Y, Lefebvre Y, et al. Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling. Prostate Cancer Prostatic Dis. 2023;26(3):575\u201380. https:\/\/doi.org\/10.1038\/s41391-022-00620-8.","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"15","key":"17980_CR16","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3390\/diagnostics13152608","volume":"13","author":"M Tomioka","year":"2023","unstructured":"Tomioka M, Seike K, Uno H, et al. Perilesional targeted biopsy combined with MRI-TRUS image fusion-guided targeted prostate biopsy: an analysis according to PI-RADS Scores. Diagnostics (Basel). 2023;13(15):2608. https:\/\/doi.org\/10.3390\/diagnostics13152608.","journal-title":"Diagnostics (Basel)."},{"issue":"17","key":"17980_CR17","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.3390\/jcm12175612","volume":"12","author":"W Malewski","year":"2023","unstructured":"Malewski W, Milecki T, Szempli\u0144ski S, et al. Prostate biopsy in the case of PIRADS 5-Is systematic biopsy mandatory? J Clin Med. 2023;12(17):5612. https:\/\/doi.org\/10.3390\/jcm12175612.","journal-title":"J Clin Med."},{"issue":"4","key":"17980_CR18","doi-asserted-by":"publisher","first-page":"235.e1","DOI":"10.1016\/j.urolonc.2020.12.015","volume":"39","author":"JN Drobish","year":"2021","unstructured":"Drobish JN, Bevill MD, Tracy CR, et al. Do patients with a PI-RADS 5 lesion identified on magnetic resonance imaging require systematic biopsy in addition to targeted biopsy? Urol Oncol. 2021;39(4):235.e1-235.e4. https:\/\/doi.org\/10.1016\/j.urolonc.2020.12.015.","journal-title":"Urol Oncol."},{"issue":"6","key":"17980_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.eururo.2013.01.035","volume":"63","author":"X Jiang","year":"2013","unstructured":"Jiang X, Zhu S, Feng G, et al. Is an initial saturation prostate biopsy scheme better than an extended scheme for detection of prostate cancer? A systematic review and meta-analysis. Eur Urol. 2013;63(6):1031\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2013.01.035.","journal-title":"Eur Urol."},{"issue":"8","key":"17980_CR20","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/diagnostics11081335","volume":"11","author":"E Gomez-Gomez","year":"2021","unstructured":"Gomez-Gomez E, Moreno Sorribas S, Valero-Rosa J, et al. Does adding standard systematic biopsy to targeted prostate biopsy in PI-RADS 3 to 5 lesions enhance the detection of clinically significant prostate cancer? Should all patients with PI-RADS 3 undergo targeted biopsy? Diagnostics (Basel). 2021;11(8):1335. https:\/\/doi.org\/10.3390\/diagnostics11081335.","journal-title":"Diagnostics (Basel)."},{"issue":"18","key":"17980_CR21","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/cncr.34355","volume":"128","author":"AM Fang","year":"2022","unstructured":"Fang AM, Shumaker LA, Martin KD, et al. Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions. Cancer. 2022;128(18):3287\u201396. https:\/\/doi.org\/10.1002\/cncr.34355.","journal-title":"Cancer."},{"issue":"5","key":"17980_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/bju.15563","volume":"129","author":"RG Rahota","year":"2022","unstructured":"Rahota RG, Diamand R, Malavaud B, et al. Pathological features of prostate imaging reporting and data system (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens. BJU Int. 2022;129(5):621\u20136. https:\/\/doi.org\/10.1111\/bju.15563.","journal-title":"BJU Int."},{"issue":"2","key":"17980_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.juro.2016.07.084","volume":"197","author":"A Priester","year":"2017","unstructured":"Priester A, Natarajan S, Khoshnoodi P, et al. Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol. 2017;197(2):320\u20136. https:\/\/doi.org\/10.1016\/j.juro.2016.07.084.","journal-title":"J Urol."},{"issue":"1","key":"17980_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13244-023-01450-5","volume":"14","author":"W Ageeli","year":"2023","unstructured":"Ageeli W, Soha N, Zhang X, et al. Preoperative imaging accuracy in size determination of prostate cancer in men undergoing radical prostatectomy for clinically localised disease. Insights Imaging. 2023;14(1):105. https:\/\/doi.org\/10.1186\/s13244-023-01450-5.","journal-title":"Insights Imaging."}],"updated-by":[{"DOI":"10.1245\/s10434-025-18172-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17980-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17980-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17980-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:09:00Z","timestamp":1765289340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17980-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["17980"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17980-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-025-18172-1","URL":"https:\/\/doi.org\/10.1245\/s10434-025-18172-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study protocol was reviewed and approved by the institutional review board of the Second Hospital of Tianjin Medical University Hospital (no. KY2020K170). Informed consent was obtained from all the subjects when they were enrolled.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}